Cheng CY, Hao WR, Liu JC, Cheng TH. Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies. World J Diabetes 2024; 15(12): 2370-2375 [PMID: 39676805 DOI: 10.4239/wjd.v15.i12.2370]
Please LOGIN to submit a new comment.